Table 1 Means and standard deviations or percentages at baseline of the control and experimental groups and their tests for statistical differences.

From: A randomised clinical trial comparing 35 Hz versus 50 Hz frequency stimulation effects on hand motor recovery in older adults after stroke

Variable

50 Hz NMES group (n  = 20)

35 Hz NMES group (n  = 21)

Control group (n  = 20)

P value

Gender (% male)

65

51.7

60

0.948

Age (years)

71.25 (6.99)

70.14 (7.25)

71.50 (7.56)

0.816

BMI (kg/m2)

25.33 (2.35)

24.49 (2.31)

26.19 (2.99)

0.114

Time post-stroke (months)

5.30 (2.13)

6.19 (3.92)

5.80 (3.24)

0.673

MMSE

27.10 (3.89)

27.81 (3.34)

27.35 (3.59)

0.816

Stroke (% ischemic)

75

61.9

80

0.45

Hemiparesis (% right)

55

52.4

40

0.648

Aphasia (%)

20

9.5

5

0.373

Dominant hand (% right)

100

95.2

95

1

Shoulder control motor (%)

65

47.6

50

0.523

Hypertension (%)

40

47.6

45

0.949

Diabetes (%)

35

23.8

35

0.735

Ex-smokers (%)

60

33.3

45

0.26

Pain (%)

70

71.4

55

0.501

Wrist resting angle (º)

− 10.50 (10.87)

− 10.48 (9.74)

− 5.50 (5.60)

0.138

Wrist active extension (º)

13.10 (6.54)

17.57 (11.89)

19.25 (18.01)

0.309

Wrist passive extension (º)

36.25 (14.77)

46.43 (12.56)

40.75 (16.65)

0.094

MCP resting angle (º)

− 35.00 (15.64)

− 37.14 (13.93)

− 29.75 (17.28)

0.308

MCP active extension (º)

6.00 (9.95)

15.24 (13.83)

12.75 (12.19)

0.05

Grip strength (kgf)

3.81 (3.01)

5.83 (4.70)

4.80 (6.30)

0.417

Pinch strength (kgf)

1.67 (1.55)

2.44 (2.12)

2.09 (2.39)

0.485

MAS score for wrist flexors

2.05 (0.99)

2.24 (0.77)

1.85 (0.75)

0.345

MAS score for MCP flexors

1.65 (1.23)

1.81 (0.98)

1.35 (1.04)

0.396

Peak EMG amplitude extensors (µV)

62.75 (52.77)

73.24 (42.40)

89.95 (112.86)

0.521

ACR extensors (%)

45.25 (12.52)

39.70 (12.65)

42.35 (12.05)

0.366

BBT

5.55 (5.52)

6.05 (7.71)

8.55 (10.05)

0.447

Barthel Index

59.50 (13.85)

60.71 (14.26)

58.25 (17.11)

0.873

  1. NMES Neuromuscular electrical stimulation, BMI Body mass index, MMSE Mini-Mental State Examination, MCP Metacarpophalangeal, MAS Modified Ashworth Scale, ACR co-activation ratio of the antagonist, BBT Box and Block Test.